Survival benefits of different immunotherapies for hepatocellular carcinoma: a meta-analysis highlighting age, gender, etiology, and tumor burden

Authors

Ming‐Cheng Guan (ORCID: https://orcid.org/0000-0002-7845-3689)
Na Li (ORCID: https://orcid.org/0009-0005-0013-3182)
Hong Zhu (ORCID: https://orcid.org/0000-0001-7502-278X)
Hao Li (ORCID: https://orcid.org/0000-0001-7191-5118)
Mei Yang (ORCID: https://orcid.org/0000-0002-4233-7889)
Sun D (ORCID: https://orcid.org/0000-0002-2692-6384)
Lei Hong (ORCID: https://orcid.org/0000-0002-1557-9209)
Qian Ding

Institutions

Jiangnan University (CN)
Soochow University (CN)
Wuxi Fourth People's Hospital (CN)
Suzhou Municipal Hospital (CN)
First Affiliated Hospital of Soochow University (CN)

Publication Details

Journal: Frontiers in Immunology
Published: 2025-12-10
DOI: https://doi.org/10.3389/fimmu.2025.1713151
Primary Topic: Hepatocellular Carcinoma Treatment and Prognosis
Type: article
Field-Weighted Citation Impact: 0.00

Funders

National Natural Science Foundation of China
Government of Jiangsu Province

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Survival benefits of different immunotherapies for hepatocellular carcinoma: a meta-analysis highlighting age, gender, etiology, and tumor burden

Ming‐Cheng Guan, Na Li, Hong Zhu, Hao Li et al.

Dec 10, 2025

Frontiers in Immunology

Hepatocellular Carcinoma Treatment and Prognosis

article

Survival benefits of different immunotherapies for hepatocellular carcinoma: a meta-analysis highlighting age, gender, etiology, and tumor burden

Ming‐Cheng Guan, Na Li, Hong Zhu, Hao Li, Mei Yang, Sun D, Lei Hong, Qian Ding

December 10, 2025article en

Abstract

No abstract available for this paper.

Frontiers in ImmunologyVol. 16

Jiangnan University (CN), Soochow University (CN), Wuxi Fourth People's Hospital (CN), Suzhou Municipal Hospital (CN), First Affiliated Hospital of Soochow University (CN)

National Natural Science Foundation of China, Government of Jiangsu Province

Openalex Percentile: Top 49%

Hepatocellular Carcinoma Treatment and Prognosis

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.